Afreen Shariff, MD, MBBS, Duke Cancer Institute, discusses the challenges and benefits of electronic consults (e-consults) for patients with cancer currently undergoing treatment who have a comorbidity history or who develop an endocrine system disorder because of treatment.
At the recent Association of Community Cancer Centers’ 40th National Oncology Conference, held October 4-6 in Austin, Texas, Afreen Shariff, MD, MBBS, director at Duke Endo-Oncology Program, Duke Endocrinology, Duke Cancer Institute, sat down for a conversation with The American Journal of Managed Care® to discuss both the challenges and benefits of electronic consults (e-consults) for patients with cancer currently undergoing treatment who have a comorbidity history or who develop an endocrine system disorder because of treatment.
Here she discusses for whom and in what conditions e-consults are a potential mode of care access.
Transcript
Are there specific patient populations or medical conditions in which e-consults can be particularly beneficial?
I think any area within cancer care can be transformed through e-consults, whether it is psychiatry, psychology care. I think the more niche you are in practice—in the sense that if it is a cardiologist that specializes in cancer therapies and cancer care, or if it is a nephrologist that specializes in cancer therapies and kind of cancer toxicities—depending on what the needs are of the practice, really, defining that and matching that with the experts around the country is where electronic consults can be very helpful. Anywhere where you identify poor access is an opportunity where electronic consults can be very well utilized.
Gaps in Access to Cancer Care Resources May Contribute to Racial, Ethnic Disparities
December 1st 2023Researchers found that core oncology services were less likely to be available at hospitals serving racial and ethnic minority groups compared with other hospitals in the United States.
Read More
Dr Alvaro Pascual-Leone Discusses Disparities in Alzheimer Disease Research
November 30th 2023Alvaro Pascual-Leone, MD, PhD, addresses the role of the gene variant APOE4 in Alzheimer disease and dementia, noting its influence on risk factors and the significance of early diagnosis for effective intervention across all racial groups.
Read More
Emily Goldberg Shares Insights as a Genetic Counselor for Breast Cancer Risk Screening
October 30th 2023On this episode of Managed Care Cast, Emily Goldberg, MS, CGC, a genetic counselor at JScreen, breaks down how genetic screening for breast cancer works and why it is so important to increase awareness and education around these screening tools available to patients who may be at risk for cancer.
Listen